Understanding how cancer care affects patients' time and well-being
Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life
This study is looking at how much time cancer patients spend on their treatment and care, using a mobile app to track their experiences, so we can find ways to make their lives easier and help them enjoy their daily activities and relationships more.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11015908 on NIH RePORTER |
What this research studies
This research investigates the time demands placed on cancer patients due to their treatment and care activities. It aims to quantify the 'time toxicity' associated with cancer care, which often leads to patients neglecting their daily life and relationships. By using a mobile health application, the study will collect both objective data and subjective reports from patients to measure how much time they spend on healthcare-related tasks. The goal is to create a scoring system that can help identify ways to reduce these time burdens and improve patients' quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults undergoing treatment for cancer who are 21 years or older.
Not a fit: Patients who are not currently receiving cancer treatment or those who are not affected by the time demands of cancer care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer care strategies that better balance treatment demands with patients' overall well-being.
How similar studies have performed: While the concept of time toxicity in cancer care is relatively novel, similar approaches in measuring patient burden have shown promise in other healthcare contexts.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Vogel, Rachel Isaksson — University of Minnesota
- Study coordinator: Vogel, Rachel Isaksson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.